5Bischoff-Ferrari HA,Dawson-Hughes B,Willett WC,et al.Effect of vitamin D on falls:a meta-analysis[J].JAMA,2004;291(16):1999-2006.
6Russell RG.Related articles,bisphosphonates:mode of action and pharmacology[J].Pediatrics,2007;119 (Suppl 2):S150-62.
7Kong YY,Feige U,Sarosi I,et al.Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand[J].Nature,1999;402(6759):304-9.
8Reginster JY.Treatment of postmenopausal osteoporosis[J].BMJ,2005;330(7505):859-60.
9Reginster JY,Devogelaer JP.Raloxifene reduces fractures in postmenopausal women with osteoporosis[J].Clin Orthop Relat Res,2006;443(1):48-54.
10Ettinger B,Black DM,Mitlak BH,et al.Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene:results from a 3 year randomized clinical trial.Multiple Outcomes of Raloxifene Evaluation(MORE) Investigators[J].JAMA,1999;282(7):637-45.
4NIH Consensus Development Panel Osteoporosis Prevention Diagnosis and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA, 2001,285:785-795.
5Stein GS, Lian JB, Stein JL, et al. Transcriptional control of ostcoblast growth and differentiation. Physiol Revi, 1996,76:593-599.
6McGuigan FE, Reid DM, Ralston SH. Susceptibility to osteoporotic fracture is determined by alldic variation at the Sp1 site, rather than other polymorphic sites at the COLIA1 locus. Osteoporos Int, 2000,11 :338-343.
7Gorai I, Taguchi Y, Chaki O, et al. Specific changes of urinary excretion of cross-linked N-telopeptides of type Ⅰ collagen in pre- and postmenpausal women: correlation with other markers of bone turnover.Calcif Tissue Int, 1997,60:317-322.
8Rosen HN, Moses AC, Gather J, et al. Vitality of biochemical markers of bone turnover in the follow-up of patients treatment with biphosphonates. Caleif Tissue Int, 1998,63:363-368.
9Rosen CJ, Chesnut CH, Mallinak NJS. The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supple mentation. J Clin Endocrinol Metab, 1997,82:1904-1910.
10Taguchi Y, Gorai I, Zhang MG, et al. Difference in bone resorption after menopause in Japanese woman with normal or low bone mineral density: Quantitation of urinary cross-linked N-telopeptides. Calcil Tissue Int, 1998,67:395-399.
